ClinPhone Pro
Our next-generation unified RTSM / IRT platform. Randomization, participant management, drug supply, and reporting in one connected system, built for multi-arm, dose-escalation, and basket or umbrella oncology designs.
Learn MoreDose-escalation cohorts, basket and umbrella studies, adaptive randomization, cold-chain supply. Our RTSM technology and experts are built to hold that complexity, from first participant in to database lock.
30 years of RTSM experience across oncology programs worldwide.
The products and expertise we bring to oncology clinical trials, from complex randomization and cold-chain supply through to eCOA and study-design consultancy.
Solutions
Our next-generation unified RTSM / IRT platform. Randomization, participant management, drug supply, and reporting in one connected system, built for multi-arm, dose-escalation, and basket or umbrella oncology designs.
Learn MoreStreamlined, ready-to-deploy RTSM on the same platform and quality framework, with go-live in about four weeks. A right-fit option for early-phase and investigator-led oncology studies that need proven capability fast.
Learn MoreElectronic Clinical Outcome Assessment through our Kayentis partnership, available as an integrated RTSM plus eCOA solution to capture patient-reported symptoms and quality-of-life data alongside randomization and dosing.
Learn MoreSupply-chain and randomization consultancy plus expert training, designed to de-risk adaptive and dose-finding oncology designs before and during the study.
Learn MoreServices
End-to-end RTSM design, implementation, integration, validation, deployment, and support for oncology protocols, delivered by an embedded team of experts.
Learn MoreExpert design of randomization and stratification strategy for dose-escalation, seamless Phase I/II, basket, umbrella, and platform oncology protocols.
Learn MoreForecasting and supply modeling to reduce waste and protect continuity of high-value, temperature-sensitive, and short-expiry IMP.
Learn MoreThe four capability areas behind every study we run, applied to the specific demands of oncology clinical trials.
Blocked, stratified, dynamic, and response-adaptive randomization for multi-arm, dose-escalation, and seamless Phase I/II oncology protocols.
Forecast-driven resupply, depot-to-site logistics, and lot and expiry management for cold-chain and short-shelf-life oncology IMP.
Cohort enrollment and expansion, visit scheduling, participant replacement, and emergency unblinding across long oncology treatment periods.
Audit trails, data-change reporting, and real-time dashboards designed to support inspection readiness for oncology submissions.

A look at how standardized configurations and expert support shortened study start-up — and what teams running Phase II and III trials can take from it.
July 24, 2026
Talk with our RTSM experts about the randomization, drug-supply, and data challenges specific to your oncology protocol.